vimarsana.com
Home
Live Updates
Abbott Announces Development of Novel Continuous Glucose-Ket
Abbott Announces Development of Novel Continuous Glucose-Ket
Abbott Announces Development of Novel Continuous Glucose-Ketone Monitoring System
/PRNewswire/ -- Abbott (NYSE: ABT) today announced it's developing a new biowearable that will continuously monitor glucose and ketone levels in one sensor....
Related Keywords
United States ,
Kansas ,
Overland Park ,
Aaronj Kowalski ,
Jared Watkin ,
Kurt Midyett ,
Linkedin ,
Drug Administration ,
Facebook ,
National Diabetes Statistics ,
Freestyle Libre ,
Continuous Glucose Ketone ,
Midwest Pediatric Specialists ,
Abbott Diabetes ,
Diabetes Statistics Report ,
Its Burden ,
Accessed May ,
Ketone Testing ,
Patients With Type ,
Rev Diabet ,
Ketone Monitoring Consensus Report ,
Diabetes Science ,
Clinical Case ,
Ketone Sensor ,
Closed Loop Insulin Pump ,
Abbott ,